KEY FEATURES
| Full Name | Suppressors Of Cytokine Signaling 3 |
|---|---|
| Synonym | ATOD4; CIS3; Cish3; MGC71791; SOCS-3; SSI-3; SSI3; Cytokine-inducible SH2 protein 3; STAT-induced STAT inhibitor 3 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.6-1000pg/mL |
| Sensitivity | 5.6pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human SOCS3 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human SOCS3. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human SOCS3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human SOCS3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human SOCS3. You can calculate the concentration of Human SOCS3 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human SOCS3 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 51.18 | 152.49 | 385 | 50.18 | 157.37 | 362.81 |
| Standard deviation | 3.5 | 6.86 | 16.25 | 2.65 | 7.08 | 19.77 |
| CV(%) | 6.84 | 4.5 | 4.22 | 5.28 | 4.5 | 5.45 |
RECOVERY
The recovery of Human SOCS3 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 91-103 | 97 |
| EDTA plasma (n=8) | 87-100 | 94 |
| Cell culture media (n=8) | 93-107 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human SOCS3 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with SOCS3 ELISA Kits
| STAT3 ELISA Kit | publications with SOCS3 and STAT3 |
| JAK2 ELISA Kit | publications with SOCS3 and JAK2 |
| JAK1 ELISA Kit | publications with SOCS3 and JAK1 |
| IRS1 ELISA Kit | publications with SOCS3 and IRS1 |
| IL6ST ELISA Kit | publications with SOCS3 and IL6ST |
| PTPN11 ELISA Kit | publications with SOCS3 and PTPN11 |
| STAT5B ELISA Kit | publications with SOCS3 and STAT5B |
| JAK3 ELISA Kit | publications with SOCS3 and JAK3 |
| STAT5A ELISA Kit | publications with SOCS3 and STAT5A |
| INSR ELISA Kit | publications with SOCS3 and INSR |
Pathways associated with SOCS3 ELISA Kit
| ATF-2 Transcription Factor Network Pathway | ATF-2 Transcription Factor Network Pathway |
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| Adipocytokine Signaling Pathway | Adipocytokine Signaling Pathway |
| Adipogenesis Pathway | Adipogenesis Pathway |
| Antigen Processing: Ubiquitination & Proteasome Degradation Pathway | Antigen Processing: Ubiquitination & Proteasome Degradation Pathway |
| Apoptosis-related Network Due To Altered Notch3 In Ovarian Cancer Pathway | Apoptosis-related Network Due To Altered Notch3 In Ovarian Cancer Pathway |
| Class I MHC Mediated Antigen Processing & Presentation Pathway | Class I MHC Mediated Antigen Processing & Presentation Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| ECS Complex Pathway | ECS Complex Pathway |
Diseases associated with SOCS3 ELISA Kit
| Inflammation | publications with SOCS3 and Inflammation |
| Necrosis | publications with SOCS3 and Necrosis |
| Disease Models, Animal | publications with SOCS3 and Disease Models, Animal |
| Liver Diseases | publications with SOCS3 and Liver Diseases |
| Nervous System Diseases | publications with SOCS3 and Nervous System Diseases |
| Cardiovascular Diseases | publications with SOCS3 and Cardiovascular Diseases |
| Carcinoma, Hepatocellular | publications with SOCS3 and Carcinoma, Hepatocellular |
| Liver Neoplasms | publications with SOCS3 and Liver Neoplasms |
| Heart Diseases | publications with SOCS3 and Heart Diseases |
| Fibrosis | publications with SOCS3 and Fibrosis |
Organs/Tissues associated with SOCS3 ELISA Kit
| Blood | publications with SOCS3 and Blood |
| Liver | publications with SOCS3 and Liver |
| Brain | publications with SOCS3 and Brain |
| Adipose Tissue | publications with SOCS3 and Adipose Tissue |
| Bone | publications with SOCS3 and Bone |
| Lung | publications with SOCS3 and Lung |
| Vascular | publications with SOCS3 and Vascular |
| Heart | publications with SOCS3 and Heart |
| Connective Tissue | publications with SOCS3 and Connective Tissue |
| Kidney | publications with SOCS3 and Kidney |